PAIN
Volume 146, Issue 3 , Pages 261-269 , 5 December 2009

A systematic review of adverse events in placebo groups of anti-migraine clinical trials

  • Martina Amanzio

      Affiliations

    • Department of Psychology, University of Turin, Via Verdi 10, 10123 Turin, Italy
    • Neuroscience Institute of Turin (NIT), University of Turin, Italy
    • Corresponding Author InformationCorresponding author. Address: Department of Psychology, University of Turin, Via Verdi 10, 10123 Turin, Italy. Tel.: +39 11 6702468; fax: +39 11 6702061.
    • ,
  • Luca Latini Corazzini

      Affiliations

    • Department of Psychology, University of Turin, Via Verdi 10, 10123 Turin, Italy
    • Neuroscience Institute of Turin (NIT), University of Turin, Italy
    • ,
  • Lene Vase

      Affiliations

    • Department of Psychology, University of Aarhus, Jens Chr. Skous Vej 4, DK – 8000 Århus C, Denmark
    • ,
  • Fabrizio Benedetti

      Affiliations

    • Department of Neuroscience, University of Turin Medical School, Corso Raffaello 30, 10125 Turin, Italy
    • National Institute of Neuroscience (INN), Turin, Italy

Received 24 March 2009 ,Revised 4 June 2009 ,Accepted 13 July 2009.

References 

  1. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90:205–215
  2. Barsky AJ. Amplification, somatization, and the somatoform disorders. Psychosomatics. 1992;33:28–34
  3. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol. 2008;48:33–60
  4. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci. 2006;26:12014–12022
  5. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience. 2007;147:260–271
  6. Burke A, Smyth EM, Fitzgerald GA. Analgesic-antipyretic and antiinflammatory agents, pharmacotherapy of gout. In:  Brunton LL,  Lazo JS,  Parker K editor. Goodman & Gilman’s. The pharmacological basis of therapeutics. 11th ed.. New York: Mc Graw-Hill; 2006;p. 671–716
  7. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron. 2008;59:195–206
  8. Flaten MA, Simonsen T, Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med. 1999;61:250–255
  9. Gracely RH, Dubner R, Wolskee PJ, Deeter WR. Placebo and naloxone can alter postsurgical pain by separate mechanisms. Nature. 1983;306:264–265
  10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  11. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol. 1985;40:1189–1202
  12. Kong J, Gallub RL, Polich G, Kirsch I, Laviolette P, Vangel M, et al. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci. 2009;28:13354–13362
  13. Levine ME, Stern RM, Koch KL. The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea. Psychosom Med. 2006;68:478–486
  14. Liccardi G, Senna G, Russo M, Bonadonna P, Crivellaro M, Dama A, et al. Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. J Investig Allergol Clin Immunol. 2004;14:104–107
  15. McNamara JO. Pharmacotherapy of the epilepsies. In:  Brunton LL,  Lazo JS,  Parker K editor. Goodman & Gilman’s. The pharmacological basis of therapeutics. 11th ed.. New York: Mc Graw-Hill; 2006;p. 501–526
  16. Peroutka SJ. Drugs effective in the therapy of migraine. In:  Hardman JG,  Limbird LE editor. Goodman & Gilman’s. The pharmacological basis of therapeutics. 9th ed.. New York: Mc Graw-Hill; 1996;p. 487–502
  17. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565–590
  18. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups. Implications for assessment of adverse effects. Arch Int Med. 2006;166:155–160
  19. Rosenthal R. Experimenter effects in behavioral research. New York: Appleton Century Crofts; 1966;
  20. Runyon RP, Haber A. Fundamentals of behavioral statistics. Addison-Wesley: Publishing Company; 1971;
  21. Vase L, Robinsen ME, Verne GN, Price DD. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain. 2005;115:338–347
  22. Vase L, Price DD, Verne GN, Robinson ME. The contribution of changes in expected pain levels and desire for pain relief to placebo analgesia. In: Price DD, Bushnell MC, editors. Psychological methods of pain control: basic science and clinical perspectives, progress in pain research and management. Seattle: IAPS Press; 2004. p. 207–32.

PII: S0304-3959(09)00399-6

doi: 10.1016/j.pain.2009.07.010

PAIN
Volume 146, Issue 3 , Pages 261-269 , 5 December 2009

Article Tools

* Image Usage & Resolution